Home > Cashflow Statement > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
AD     Remove this Ad

SOTAC PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹16 Cr₹29 Cr₹13 Cr₹-2.83 Cr₹3.38 Cr

What is the latest Cash Flow from Financing Activities ratio of SOTAC PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of SOTAC PHARMACEUTICALS is ₹16 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹16 Cr
Mar2024₹29 Cr
Mar2023₹13 Cr
Mar2022₹-2.83 Cr
Mar2021₹3.38 Cr

How is Cash Flow from Financing Activities of SOTAC PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹16 Cr
-45.43
Mar2024 ₹29 Cr
124.51
Mar2023 ₹13 Cr
Positive
Mar2022 ₹-2.83 Cr
Negative
Mar2021 ₹3.38 Cr -

Compare Cash Flow from Financing Activities of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹119.9 Cr -2.3% -12.3% -10.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -1.4% -3.2% -0.5% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -1.9% -8.7% 1.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -3.5% -6.6% 30.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -4% -8.3% 6.3% Stock Analytics
CIPLA ₹96,400.8 Cr -1.9% -11.9% -19% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

-2.3%

-12.3%

-10.5%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses